2cureX AB (publ) (2CUREX.ST)

STO • Currency in SEK

kr 2.44

+kr 0.10

+4.27%

Last Update: 29 Aug 2025, 14:18

kr 61.25M

Market Cap

0.00

P/E Ratio (TTM)

3.44%

Forward Dividend Yield

kr 0.33 - kr 5.52

52 Week Range

2CUREX.ST Stock Price Chart

Explore 2cureX AB (publ) interactive price chart. Choose custom timeframes to analyze 2CUREX.ST price movements and trends.

2CUREX.ST Company Profile

Discover essential business fundamentals and corporate details for 2cureX AB (publ) (2CUREX.ST) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

24 Nov 2017

Employees

14.00

Website

https://www.2curex.com

CEO

Dan Honeywell

Description

2cureX AB (publ) operates as a medtech company in Europe. Its principal product is IndiTreat, an IVD test, which helps to predict cancer patient's response and resistance to different drugs and select the appropriate treatment. The company is also conducting various clinical programs for IndiTreat for breast colorectal, ovarian, and pancreatic cancers. 2cureX AB (publ) was incorporated in 2006 and is based in Copenhagen, Denmark.

2CUREX.ST Financial Timeline

Browse a chronological timeline of 2cureX AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 26 Feb 2026

Earnings released on 21 Aug 2025

Dividend declared on 27 Jun 2025

A dividend of kr 0.08 per share was announced, adjusted to kr 0.08. The dividend was paid on 3 Jul 2025.

Earnings released on 27 Feb 2025

Earnings released on 22 Aug 2024

EPS came in at -kr 0.27 , while revenue for the quarter reached kr 250.00K .

Earnings released on 24 May 2024

EPS came in at -kr 0.27 , while revenue for the quarter reached kr 250.00K .

Earnings released on 23 Feb 2024

EPS came in at -kr 0.28 , while revenue for the quarter reached kr 592.00K .

Earnings released on 23 Nov 2023

EPS came in at -kr 0.58 , while revenue for the quarter reached kr 87.00K .

Earnings released on 24 Aug 2023

EPS came in at -kr 0.46 , while revenue for the quarter reached kr 67.00K .

Earnings released on 25 May 2023

EPS came in at -kr 0.54 , while revenue for the quarter reached kr 82.00K .

Earnings released on 31 Mar 2023

EPS came in at -kr 0.38 , while revenue for the quarter reached kr 13.00K .

Earnings released on 30 Sept 2022

EPS came in at -kr 0.41 , while revenue for the quarter reached kr 8.00K .

Earnings released on 30 Jun 2022

EPS came in at -kr 0.30 , while revenue for the quarter reached kr 8.00K .

Earnings released on 31 Mar 2022

EPS came in at -kr 0.44 , while revenue for the quarter reached kr 434.00K .

Earnings released on 24 Feb 2022

EPS came in at -kr 0.38 , while revenue for the quarter reached kr 2.54M .

Earnings released on 26 Nov 2021

EPS came in at -kr 0.31 , while revenue for the quarter reached kr 530.00K .

Earnings released on 26 Aug 2021

EPS came in at -kr 0.35 , while revenue for the quarter reached kr 469.00K .

Earnings released on 27 May 2021

EPS came in at -kr 0.12 , while revenue for the quarter reached kr 3.85M .

Earnings released on 26 Feb 2021

EPS came in at -kr 0.06 , while revenue for the quarter reached kr 4.17M .

Earnings released on 31 Dec 2020

EPS came in at -kr 0.15 , while revenue for the quarter reached kr 5.21M .

2CUREX.ST Stock Performance

Access detailed 2CUREX.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.